EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China

Xiaoqing Jia, Xiaoting Zhang, Tao Zhou, Dalong Sun, Rong Li, Na Yang, Zheng Luo

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0295184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Xiaoqing Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Alcohol Drinking, Cytochrome P-450 CYP3A. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We investigated the epidemiology of Cytochrome P450 (CYP) 3A4 genotype and the relationship between CYP3A4 genotype and alcohol drinking habits. Materials and methods A single-centered retrospective study was conducted on 630 patients who underwent CYP3A4*1G genetic testing. Their relevant information on epidemiology and etiology was collected. Laboratory testing, including CYP3A4*1G genotype, liver function tests, and serum lipid measurements were performed. Bi-variate logistic regressions were used to examine the relationship between variables. The relationship between alcohol drinking and CYP3A4*1G genotype was estimated. Demographic and clinical features were analyzed. Participants with drinking history were divided into non-heavy drinking and heavy drinking groups. Liver function and dyslipidemia of participants with drinking histories were compared between CYP3A4*1G mutation (GA+AA) and wild-type (GG) groups.

Results

Participants with CYP3A4*1G mutation(GA+AA) had an increased adjusted odds ratio (AOR) of 2.56 (95% CI, 1.4–4.65; P = 0.00) for alcohol abuse when compared with participants without CYP3A4 mutation (GG). In the subgroup of participants with alcohol abuse, there are no significant differences in liver injury levels and serum lipid levels between CYP3A4*1G mutant and wild-type groups. Patients with CYP3A4*1G mutation had an increased AOR of cardiac-vascular diseases and malignant diseases compared with patients without CYP3A4*1G mutation. The epidemiology had no difference between GA and AA group.

Conclusion

The study indicated that there was association between alcohol drinking and CYP3A4*1G genetic mutation. In the subgroup of participants with alcohol abuse, there are no significant differences in liver injury and dyslipidemia between CYP3A4*1G mutant and wild-type groups. CYP3A4*1G mutation was also related to cardiac-vascular diseases and malignant diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol DrinkingCytochrome P-450 CYP3ARetrospective StudiesHumansGenotypeAlcoholismChinaMaleAdultMiddle AgedAgedDyslipidemiasLiver

Substanzen

Cytochrome P-450 CYP3ACYP3A protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
  • Department of Geriatric Medicine, Qilu Hospital, Shandong University, Jinan, Shandong, China.

Zitieren

APA

Jia, X., Zhang, X., Zhou, T., Sun, D., Li, R., Yang, N., & Luo, Z. (2023). Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China. PLOS ONE. https://doi.org/10.1371/journal.pone.0295184

Vancouver

Jia X, Zhang X, Zhou T, Sun D, Li R, Yang N, et al. Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China. PLOS ONE. 2023. doi:10.1371/journal.pone.0295184

BibTeX
@article{Jia2023,
  author = {Jia, Xiaoqing and Zhang, Xiaoting and Zhou, Tao and Sun, Dalong and Li, Rong and Yang, Na and Luo, Zheng},
  title = {Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0295184}
}
Kostenlos starten →